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Although not widely availble when this trial was
initiated in 1978, endoscopic treatment (sclerosis
and banding) has become the mainstay in most
centers for management of the acute variceal
bleeder with bleeding control rates in excess of
70% in nearly all series[4,5,6]. Additionally,
other effective non-operative therapies such as
transjugular intrahepatic portosystemic shunt
(TIPS)[7] and intravenous octreotide[4,8] have
been introduced since the completion of this
trial. Since a TIPS accomplishes portal decom-
pression in a manner similar to a surgical shunt,
it would be expected to relieve variceal bleeding
as well, with potentially less morbidity, espe-
cially in high risk patients. Patients treated with
TIPS often improve their liver function, but
those who deteriorate due to inadequate func-
tional hepatic reserve can be considered for liver
transplantation. Unlike patients with surgical
shunts, TIPS does not increase, and in fact may
decrease the risk of liver transplantation.
Since the results of this trial, which enrolled
patients from 1978 to 1983 but which was not
published until 1994, may have limited rele-
vance to the management of acute variceal
bleeding in 1996, the results of an ongoing trial
of EPCS versus endoscopic treatment by Orloff’s
group are eagerly awaited. Will this provide a
definitive answer? Probably not, because TIPS is
now available for high-risk patients who fail
emergency endoscopic treatment. In fact, it is
unlikely that any single therapy will ever be
uniformly applicable to this heterogeneous
group of patients. Now that several effective
modalities are available, a thoughtful, individua-
lized approach is essential to obtain optimal results.
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ABSTRACT
Siringo, S., Bolondi, L., Gaiani, S., Sofia, S., Zironi,
G., Rigamonti, A., Di Febo, G., Miglioli, M., Cavalli,
G. and Barbara, L. (1994). Timing of the first variceal
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tion of doppler flowmetry, endoscopy and clinical
parameters. Hepatology; 20: 66-73.
We followed 87 cirrhotic patients with esopha-
geal varices and without previous hemorrhage
for a mean period of 24 mo to prospectively
evaluate the occurance of variceal bleeding
within (early) or after (late) 6 mo from entry
and the contribution of portal Doppler ultra-
sound parameters to the prediction of early and
late hemorrhage. Clinical, biochemical, endo-
scopic and portal Doppler ultrasound para-
meters were recorded at entry. Variceal
bleeding occurred in 22 patients (25.3%). Nine
(40.9%) bled within the first 6 mo. Cox
regression analysis identified variceal size,
cherry-red spots, serum bilirubin and conges-
tion index of the portal vein (the ratio of portal
vein [cross-sectional area] and portal blood
flow velocity) as the only independent pre-
dictors of first variceal hemorrhage. Discrimi-
nant analysis was used to find the prognostic
index cut off points to identify patients who
bled within 6 mo (prognostic group 1) or after 6
mo (prognostic group 2) or remained free of
bleeding (prognostic group 3). The cumulative
proportion of patients correctly classified was
73% in prognostic group 1, 47% in prognostic
group 2 and more than 80% in prognostic
group 3. The addition of Doppler ultrasound
flowmetry to clinical, biochemical and endo-
scopic parameter only improved the classifica-
tion of patients with early bleeding.
(Hepatology 1994; 20: 66-73.)
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PAPER DISCUSSION
Approximately, 25 to 30% of cirrhotic patients
with esophageal varices and without previous
variceal hemorrhage will bleed from ruptured
varices and 70% of them will do so within the
first two years of follow-up [1]. However,
studies evaluating the risk factors for the first
variceal bleeding have not assessed the timing of
the variceal bleeding during this period [2-4].
The assessment of these patients suggest [5] that
the risk of bleeding within the first two years is
not constant; it tends to decrease after an inital
period of six months. Therefore, the identifica-
tion of risk factors for early and late bleeding is
important because it could allow randomization
of patients into different treatment groups in
prophylactic trial for the prevention of a first
variceal hemorrhage, i.e. by betablockers or
endoscopic sclerotherapy.
Risk factors for a high bleeding risk have been
described by our group [6], by the Japanese
Research Society for Portal Hypertenion[7] and
by the North Italian Endoscopy Club[2]. How-
ever, in these description the role of portal
hemodynamics in the prediction of variceal
bleeding are not included. The New Haven
Group [8] has described the prevalence of a
certain level of portal pressure for the risk of
variceal bleeding. Therefore, this additional risk
factor was included in a prospective rando-
mized trial of prophylactic endoscopic sclero-
therapy of our group and seems to be very
useful [9].
However, this selection criterion is invasive
and thus has limits. Doppler ultrasound is a new
tool for evaluating portal hypertension, provid-
ing a non invasive assessment of blood flow in
most splanchnic vessels. The current use of
doppler ultrasound has focused on studies of
pathophysiology of portal hypertention and on
assessment of effects of vasoactive drugs on
splanchnic blood flow. Early studies of portal
hemodynamics in cirrhotic patients may have a
potential prognostic value in assessment of the
risk of variceal bleeding [12].
Therefore, the group of Siringo prospectively
evaluated the (a) occurrence of the first variceal
bleeding, defined hemorrhage occurring within
six months of entry into control studies, and lateHPB INTERNATIONAL 257
first variceal bleeding (i.e. bleeding occuring
after six months of follow-up), and (b) the role of
portal doppler ultrasound parameters, in addi-
tion to clinical and endoscopic criteria, in
predicting the early and late occurrence of
hemorrhage, as well as the possibility of patients
remaining free of bleeding.
Therefore, during the period of 38 months, 95
consecutive cirrhotic patients with esophageal
varices and without previous variceal hemor-
rhage were subjected to doppler ultrasound
evaluation. The doppler ultrasound was techni-
cal feasible in 87 patients (91,6%), who were
subseqently followed up for a mean period of
24,0 (4-14,5) months. 71 (81.6%) of the 87 were
inpatients when they entered the study. At
entry, the patients underwent upper gastroin-
testinal endoscopy, and varices were classified
according to the Japanese Research Society of
portal hypertension endoscopic rule [7]. Clinical
and biochemical data were recorded in each
patient, and the severity of the liver disease was
assessed using the Cambell numeral modifica-
tion of Child’s grading[13].
The following portal hemodynamic para-
meters were evaluated in the 87 patients by
means of real-time ultrasound equipment with a
3,5-MHz-convex transducer with a pulse dop-
pler device working at 3,5 and 2,5 MHz
frequencies:
a) Diameter of the portal vein (PV) (mm) was
calculated as the anteroposterior diameter dur-
ing suspended respiration at the largest point.
b) Blood flow velocity of the portal vein (PV)
(cm/min.) was calculated with the equipment
from the doppler spectrum described by
Gill[14]. The mean velocity (Vmean) of portal
flOW was measured. The sample volume, as
large as at least half of the vessels caliber was
positioned lcm distal to the crossing point of the
hepatic artery with the portal trunk in an
oblique, subcostal scan.
c) Portal blood flow volume (PFV) (mm/min.)
was calculated by the formula FVF=Vmean r .2
where r represents the diameter of the vessel.
d) Congestion index of the portal vein (CI):
ratio of cross-sectional area and the blood flow
velocity in the portal vein. The CI was calculated
according to a modified Moriyasus’s formula
(15) using the Vmean instead of the maximal flow
velocity.
CI (r)2 "r/10
Wmean
where r is the vessels radius. For example, a
portal vein diameter of 16mm and a portal flow
velocity of 12 cm/min, yields a CI of 1.67.
In additon, the group of Siringo searched for
spontaneous portal-systemic shunts and portal
vein thrombosis in all patients. These two
variables were referred to as morphological
ultrasonographic findings.
The diagnosis of variceal hemorrhage was
made when after an episode of hematemesis,
melena or both emergency endoscopy (within 72
hours of the clinical manifestation of bleeding or
index bleed), showed (a) active bleeding, a clot
or a "white nipple" on a varix; (b) no lesions
potentially responsible for bleeding when
varices lacked the previously described signs;
or (c) potential sources of hemorrhage other than
varices but without signs of active or recent
bleeding. Patients who did not undergo emer-
gency endoscopy were considered to have bled
from an unknown source. In this case the varices
were considered the source of bleeding.
Thereafter, an univariate and multivariate
analysis and a development of a prognostic
model was performed including the mentioned
risk factors. In this discriminant analysis the
prognostic index, cut off points were found to
identify patients who bled within 6 months
(prognostic group I), after 6 six months (prog-
nostic group II) or remained free of bleeding
(prognostic group III). The cumulative propor-
tion of patients correctly classified was 73% in
the prognostic group I, 47% in the prognostic
group II, and more than 80% in the prognostic
group III. The addition of doppler ultrasound258 HPB INTERNATIONAL
flowmetry to clinical, biochemical and endo-
scopic parameters only improves the classifica-
tion of patients with early bleeding.
Thus, the cumulative rate of bleeding within 6
months in the group with early bleeding, as
predicted by clinical and endoscopic criteria,
was only 54%, quite poor and similar to 58%, as
predicted by the North Italian Endoscopy Index
of more than 40%[2]. The cumulative rate of
actual bleeding predicted in this group was
significantly improved (19% more) by the Con-
gestion Index. However, the identification of
patients with late occurrence of bleeding (after 6
months from entry) was poor in both models,
with or without the inclusion of the Congestion
Index (45 vs. 50%).
In conclusion, the study of Siringo et al.[5]
shows, that a subgroup of cirrhotic patients is at
a high risk of bleeding within 6 months of entry
into the study. This subgroup of patients is best
identified by a prognostic model based on
clinical, endoscopic and doppler parameters.
Patients who bled after 6 months from entry
are poorly identifiable when only the status at
entry is analyzed. Thus in this group the Con-
gestion Index only poorly improved the bleed-
ing risk criteria introduced by the North Italian
Endoscopy Club (2). However, the criteria
described by our group[9] are more reliable.
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